CIK 0001731348 · Medicinal Chemicals & Botanical Products (SIC 2833) · Nasdaq · fiscal year ends 05/31
| FY2026 | FY2025 | |
|---|---|---|
| Revenue (USD) | 915.5 M | 627.1 M |
| Net income (USD) | -121.4 M | -1.5 B |
| Diluted EPS (USD/shares) | -1.09 | -2.35 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-08 | 10-Q | FORM 10-Q | 2026-08-31 |
| 2026-10-08 | 8-K | FORM 8-K items 2.02,9.01 | 2026-10-08 |
| 2026-09-28 | ARS | ARS | 2026-05-31 |
| 2026-09-28 | DEFA14A | DEFA14A | |
| 2026-09-28 | DEF 14A | DEF 14A | 2026-11-18 |
| 2026-09-18 | PRE 14A | PRE 14A | 2026-11-18 |
| 2026-09-14 | 8-K | 8-K items 3.02 | 2026-09-08 |
| 2026-08-27 | 4 | 4 | 2026-08-26 |
| 2026-08-27 | 4 | 4 | 2026-08-26 |
| 2026-08-27 | 4 | 4 | 2026-08-26 |
| 2026-08-27 | 4 | 4 | 2026-08-26 |
| 2026-08-10 | 8-K | 8-K items 3.02 | 2026-08-04 |
| 2026-08-07 | 4 | 4 | 2026-08-06 |
| 2026-08-04 | 4 | 4 | 2026-08-04 |
| 2026-08-04 | 4 | 4 | 2026-08-03 |
| 2026-07-31 | 4 | 4 | 2026-07-29 |
| 2026-07-31 | 4 | 4 | 2026-07-29 |
| 2026-07-31 | 4 | 4 | 2026-07-29 |
| 2026-07-31 | 4 | 4 | 2026-07-29 |
| 2026-07-31 | S-8 | S-8 | |
| 2026-07-30 | 4 | 4 | 2026-07-29 |
| 2026-07-30 | 4 | 4 | 2026-07-29 |
| 2026-07-30 | 4 | 4 | 2026-07-29 |
| 2026-07-30 | 4 | 4 | 2026-07-29 |
| 2026-07-30 | 4 | 4 | 2026-07-29 |
Forms on file (last 1,000): 4 299, 8-K 159, DEFA14A 83, 3 28, 10-Q 26, 424B7 21, 8-K/A 11, 425 10. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=TLRY (0.002 USD), /gw/filings/filings?ticker=TLRY&form=8-K, /gw/filings/facts?ticker=TLRY&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange